Literature DB >> 12857982

Complement: structure, functions, evolution, and viral molecular mimicry.

Dimitrios Mastellos1, Dimitrios Morikis, Stuart N Isaacs, M Claire Holland, Cristoph W Strey, John D Lambris.   

Abstract

The complement (C') system has long been recognized as an important mediator of innate immune defense and inflammation. In recent years there is increasing evidence suggesting that complement components may also participate in non-inflammatory and developmental processes. Here we review our current work on the structural-functional aspects of C3-ligand interactions and the rational design of small-sized complement inhibitors. We present a novel, proteomics-based, approach to studying protein-protein interactions within the C' system and discuss our progress in the study of viral immune evasion strategies. Furthermore we discuss the involvement of complement proteins in organ regeneration and hematopoietic development.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12857982     DOI: 10.1385/IR:27:2-3:367

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   4.505


  90 in total

1.  Kinetic analysis of the interactions of complement receptor 2 (CR2, CD21) with its ligands C3d, iC3b, and the EBV glycoprotein gp350/220.

Authors:  M R Sarrias; S Franchini; G Canziani; E Argyropoulos; W T Moore; A Sahu; J D Lambris
Journal:  J Immunol       Date:  2001-08-01       Impact factor: 5.422

2.  Low-molecular-weight peptidic and cyclic antagonists of the receptor for the complement factor C5a.

Authors:  A M Finch; A K Wong; N J Paczkowski; S K Wadi; D J Craik; D P Fairlie; S M Taylor
Journal:  J Med Chem       Date:  1999-06-03       Impact factor: 7.446

Review 3.  Amphibian limb regeneration.

Authors:  P A Tsonis
Journal:  In Vivo       Date:  1991 Sep-Oct       Impact factor: 2.155

4.  Compstatin inhibits complement and cellular activation in whole blood in two models of extracorporeal circulation.

Authors:  B Nilsson; R Larsson; J Hong; G Elgue; K N Ekdahl; A Sahu; J D Lambris
Journal:  Blood       Date:  1998-09-01       Impact factor: 22.113

5.  Initiation of liver growth by tumor necrosis factor: deficient liver regeneration in mice lacking type I tumor necrosis factor receptor.

Authors:  Y Yamada; I Kirillova; J J Peschon; N Fausto
Journal:  Proc Natl Acad Sci U S A       Date:  1997-02-18       Impact factor: 11.205

6.  Compstatin, a peptide inhibitor of complement, exhibits species-specific binding to complement component C3.

Authors:  Arvind Sahu; Dimitrios Morikis; John D Lambris
Journal:  Mol Immunol       Date:  2003-01       Impact factor: 4.407

7.  Mechanism of complement inactivation by glycoprotein C of herpes simplex virus.

Authors:  I Kostavasili; A Sahu; H M Friedman; R J Eisenberg; G H Cohen; J D Lambris
Journal:  J Immunol       Date:  1997-02-15       Impact factor: 5.422

8.  Dissection of CR1, factor H, membrane cofactor protein, and factor B binding and functional sites in the third complement component.

Authors:  J D Lambris; Z Lao; T J Oglesby; J P Atkinson; C E Hack; J D Becherer
Journal:  J Immunol       Date:  1996-06-15       Impact factor: 5.422

9.  Vaccinia virus complement-control protein prevents antibody-dependent complement-enhanced neutralization of infectivity and contributes to virulence.

Authors:  S N Isaacs; G J Kotwal; B Moss
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-15       Impact factor: 11.205

Review 10.  Shark complement: an assessment.

Authors:  S L Smith
Journal:  Immunol Rev       Date:  1998-12       Impact factor: 12.988

View more
  18 in total

1.  Native properdin binds to Chlamydia pneumoniae and promotes complement activation.

Authors:  Claudio Cortes; V P Ferreira; Michael K Pangburn
Journal:  Infect Immun       Date:  2010-12-06       Impact factor: 3.441

2.  Complement up-regulates Runx-2 to induce pro-fibrogenic change in aortic valve interstitial cells.

Authors:  Xin-Sheng Deng; Xianzhong Meng; David Fullerton; Matthew Stone; James Jaggers
Journal:  Ann Thorac Surg       Date:  2021-02-02       Impact factor: 4.330

3.  Hepatitis B virus inhibits the expression of complement C3 and C4, in vitro and in vivo.

Authors:  Chengliang Zhu; Hui Song; Fengxia Xu; Wei Yi; Fang Liu; Xinghui Liu
Journal:  Oncol Lett       Date:  2018-03-09       Impact factor: 2.967

Review 4.  The role of complement in inflammatory diseases from behind the scenes into the spotlight.

Authors:  Maciej M Markiewski; John D Lambris
Journal:  Am J Pathol       Date:  2007-07-19       Impact factor: 4.307

5.  The complement and immunoglobulin levels in NMO patients.

Authors:  Ying Chen; Rui Li; Ai Ming Wu; Ya Qing Shu; Zheng Qi Lu; Xue Qiang Hu
Journal:  Neurol Sci       Date:  2013-07-24       Impact factor: 3.307

6.  The Vaccinia virus complement control protein modulates adaptive immune responses during infection.

Authors:  Natasha M Girgis; Brian C Dehaven; Yuhong Xiao; Edward Alexander; Kendra M Viner; Stuart N Isaacs
Journal:  J Virol       Date:  2010-12-29       Impact factor: 5.103

7.  Electrostatic modeling predicts the activities of orthopoxvirus complement control proteins.

Authors:  Georgia Sfyroera; Madan Katragadda; Dimitrios Morikis; Stuart N Isaacs; John D Lambris
Journal:  J Immunol       Date:  2005-02-15       Impact factor: 5.422

Review 8.  Molecular mechanisms of inflammation and tissue injury after major trauma--is complement the "bad guy"?

Authors:  Miriam D Neher; Sebastian Weckbach; Michael A Flierl; Markus S Huber-Lang; Philip F Stahel
Journal:  J Biomed Sci       Date:  2011-11-30       Impact factor: 8.410

9.  C5a receptor signaling prevents folate deficiency-induced neural tube defects in mice.

Authors:  Kerina J Denny; Liam G Coulthard; Angela Jeanes; Steven Lisgo; David G Simmons; Leonie K Callaway; Bogdan Wlodarczyk; Richard H Finnell; Trent M Woodruff; Stephen M Taylor
Journal:  J Immunol       Date:  2013-02-18       Impact factor: 5.422

10.  Mannan-binding lectin-associated serine protease 2 is critical for the development of renal ischemia reperfusion injury and mediates tissue injury in the absence of complement C4.

Authors:  Elham Asgari; Conrad A Farrar; Nicholas Lynch; Youssif M Ali; Silke Roscher; Cordula Stover; Wuding Zhou; Wilhelm J Schwaeble; Steven H Sacks
Journal:  FASEB J       Date:  2014-05-27       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.